Evidence map›Paper›PMID 39607656›Full record

ReviewJournal of occupational rehabilitation2026

Work Participation of Hematological Cancer Survivors After Hematopoietic Cell Transplantation: A Scoping Review.

Karine Bilodeau, Billy Vinette, Charlotte Gélinas-Gagné, Pegah Torabi, Benedicta Hartono, Marie Désilets, Imran Ahmad, Bertrand Porro

Abstract readScoping ReviewReview
PubMed Publisher
In one paragraph

Review in Journal of occupational rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Karine BilodeauFaculty of Nursing, University of Montreal, Montreal, QC, Canada. karine.bilodeau.2@umontreal.ca.ORCID http://orcid.org/0000-0002-0705-3426
Billy VinetteFaculty of Nursing, University of Montreal, Montreal, QC, Canada.ORCID http://orcid.org/0000-0003-0343-0260
Charlotte Gélinas-GagnéResearch Centre of the Maisonneuve-Rosement Hospital, Montreal, QC, Canada.ORCID http://orcid.org/0009-0003-2198-8732
Pegah TorabiResearch Centre of the Maisonneuve-Rosement Hospital, Montreal, QC, Canada.ORCID http://orcid.org/0009-0007-3101-5001
Benedicta HartonoFaculty of Nursing, University of Montreal, Montreal, QC, Canada.
Marie DésiletsCentre Intégré Universitaire de Santé et de Services Sociaux de l'Est-de-l'Île-de-Montréal, Montreal, QC, Canada.
Imran AhmadCentre Intégré Universitaire de Santé et de Services Sociaux de l'Est-de-l'Île-de-Montréal, Montreal, QC, Canada.ORCID http://orcid.org/0000-0003-1899-0164
Bertrand PorroInstitut de Cancérologie de l'Ouest, F-49055, Angers, France.ORCID http://orcid.org/0000-0002-1055-3368

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHematopoietic cell transplantation (HCT) is a common treatment for people diagnosed with hematological cancers. However, it can cause side effects that may affect work participation. This scoping review aims to provide an overview of the factors that influence the work participation of hematological cancer survivors who have undergone HCT.

methodsWe conducted a scoping review following the Joanna Briggs Institute guidelines and developed our search strategy in collaboration with a scientific librarian and searched nine databases (CINAHL, MEDLINE, EMBASE, Cochrane, PubMed, PsycINFO, Web of Science, Scopus, ProQuest Dissertations, & Theses Global) for primary studies in French or English until February 2024. Two reviewers extracted the data and analyzed it thematically. We synthesized and presented the findings using a narrative description approach.

resultsWe identified 940 publications, of which 36 met the eligibility criteria. Our findings underscore the significance of considering individuals over 50, those undergoing allogeneic HCT, women, and those with lower incomes. We noted disparities in evaluating or describing work participation.

conclusionIt is crucial for researchers and healthcare professionals in hematological care to be aware of the intersecting factors that influence work participation. There are still significant gaps in how workplace dynamics, legislation, and healthcare systems affect the return to work process.

Indexed as

Cancer SurvivorsEmploymentHematologic NeoplasmsHematopoietic Stem Cell TransplantationReturn to WorkFemaleHumansMaleCancerCellReviewTransplantationWork

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.